Mig-7 Linked to Vasculogenic Mimicry

par Robertson, Gavin P.
Publié 2007

Circulating Melanoma Cells in the Diagnosis and Monitoring of Melanoma: An Appraisal of Clinical Potential

par Mumford, Brigid, Robertson, Gavin P.
Publié dans Mol Diagn Ther (2014)

Therapeutic Interventions to Disrupt the Protein Synthetic Machinery in Melanoma

par Kardos, Gregory R., Robertson, Gavin P.
Publié dans Pigment Cell Melanoma Res (2015)

Therapeutic Implications of Targeting AKT Signaling in Melanoma

par Madhunapantula, SubbaRao V., Robertson, Gavin P.
Publié 2011

The PTEN-AKT3 Signaling Cascade as a Therapeutic Target in Melanoma

par Madhunapantula, SubbaRao V., Robertson, Gavin P.
Publié 2009

Realizing the Clinical Potential of Cancer Nanotechnology by Minimizing Toxicological and Targeted Delivery Concerns

par Singh, Sanjay, Sharma, Arati, Robertson, Gavin P.
Publié 2012

Chemoprevention of Melanoma

par Madhunapantula, SubbaRao V., Robertson, Gavin P.
Publié 2012

Use of Liposomes as Drug Delivery Vehicles for Treatment of Melanoma

par Tran, Melissa A., Watts, Rebecca J., Robertson, Gavin P.
Publié 2009

Targeting the MAPK Pathway in Melanoma: Why some approaches succeed and other fail

par Inamdar, Gajanan S, Madhunapantula, SubbaRao V., Robertson, Gavin P.
Publié 2010

Toxicological considerations when creating nanoparticle based drugs and drug delivery systems?

par Sharma, Arati, Madhunapantula, SubbaRao V., Robertson, Gavin P.
Publié 2011

Multi-Media Educational Tool Increases Knowledge of Clinical Trials in Uganda

par Castelnuovo, Barbara, Newell, Kevin, Manabe, Yukari C., Robertson, Gavin
Publié 2014

Growth Inhibitory Effects of Large Subunit Ribosomal Proteins in Melanoma

par Kardos, Gregory R., Dai, Mu-Shui, Robertson, Gavin P.
Publié dans Pigment Cell Melanoma Res (2014)

Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway

par Kardos, Gregory R., Wastyk, Hannah C., Robertson, Gavin P.
Publié dans Mol Cancer Res (2015)

The role of cholesterol in cancer

par Kuzu, Omer F., Noory, Mohammad A., Robertson, Gavin P.
Publié dans Cancer Res (2016)

The Akt signaling pathway: An emerging therapeutic target in malignant melanoma

par Madhunapantula, SubbaRao V, Mosca, Paul J, Robertson, Gavin P
Publié 2011

Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy

par Gowda, Raghavendra, Jones, Nathan R., Banerjee, Shubhadeep, Robertson, Gavin P.
Publié 2013

Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport

par Kuzu, Omer F., Gowda, Raghavendra, Sharma, Arati, Robertson, Gavin P.
Publié dans Mol Cancer Ther (2014)

Akt3 and Mutant (V600E)B-Raf Cooperate to Promote Early Melanoma Development

par Cheung, Mitchell, Sharma, Arati, Madhunapantula, SubbaRao V., Robertson, Gavin P.
Publié 2008

Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation

par Liang, Shile, Sharma, Arati, Peng, Hsin-Hsin, Robertson, Gavin, Dong, Cheng
Publié 2007

Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development

par Huh, Sung Jin, Chung, Chin-Ying, Sharma, Arati, Robertson, Gavin P.
Publié 2010